Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03900689 · ClinicalTrials.gov registry record
Social Determinants of Health in Glioblastoma Population
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 100
- Enrollment target
NCT03900689 is a clinical trial that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 100 participants.
The verdict
NCT03900689 has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
The overall aim of this study is to prospectively characterize social health disparities in a cross-sectional cohort of glioma patients with attention to exploring and thematically categorizing the patient-specific and community-level factors. This will be conducted in two parts.
Interventions
- OTHER Part 1 Survey Group
- OTHER Part 2 Focus Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2019-05-22 |
| Est. Completion | 2022-03-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03900689
The ClinicalTrials.gov registry entry for NCT03900689 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Part 1 Survey Group is the first listed.
NCT03900689 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03900689 about?
NCT03900689 is a clinical study titled "Social Determinants of Health in Glioblastoma Population". The overall aim of this study is to prospectively characterize social health disparities in a cross-sectional cohort of glioma patients with attention to exploring and thematically categorizing the patient-specific and community-level factors. This will be conducted in two parts.
What is the current status of trial NCT03900689?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2019-05-22. Estimated completion is 2022-03-27.
What interventions are being tested in trial NCT03900689?
The interventions under investigation include: Part 1 Survey Group (OTHER), Part 2 Focus Group (OTHER).
Who is sponsoring clinical trial NCT03900689?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.